May 15 (Reuters) - Achieve Life Sciences Inc ACHV.O :
* ACHIEVE REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2019 AND PROVIDES CYTISINICLINE CLINICAL DEVELOPMENT UPDATE
* ACHIEVE LIFE SCIENCES INC - QTRLY LOSS PER SHARE $0.88
* ACHIEVE LIFE SCIENCES INC - AS OF MARCH 31, 2019, COMPANY'S CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS AND RESTRICTED CASH WERE $9.7 MILLION